Vanguard Group
BOLT icon

Vanguard Group’s Bolt Biotherapeutics BOLT Stock Holding History

Vanguard Group’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$55.8K Sell
10,179
-24,052
-70% -$129K ﹤0.01% 4231
2025
Q3 		$182K Sell
34,231
-24,253
-41% -$134K ﹤0.01% 4145
2025
Q2 		$341K Sell
58,484
-1
-0% -$7 ﹤0.01% 4000
2025
Q1 		$468K Buy
58,485
+5,115
+10% +$49.2K ﹤0.01% 3905
2024
Q4 		$571K Hold
53,370
– – ﹤0.01% 3914
2024
Q3 		$692K Hold
53,370
– – ﹤0.01% 3886
2024
Q2 		$801K Buy
53,370
+1,490
+3% +$29.4K ﹤0.01% 3866
2024
Q1 		$1.45M Buy
51,880
+5,324
+11% +$123K ﹤0.01% 3694
2023
Q4 		$1.04M Buy
46,556
+343
+0.7% +$6.68K ﹤0.01% 3817
2023
Q3 		$961K Sell
46,213
-201
-0.4% -$4.91K ﹤0.01% 3843
2023
Q2 		$1.19M Hold
46,414
– – ﹤0.01% 3850
2023
Q1 		$1.29M Hold
46,414
– – ﹤0.01% 3837
2022
Q4 		$1.21M Sell
46,414
-599
-1% -$16.4K ﹤0.01% 3849
2022
Q3 		$1.39M Buy
47,013
+2,523
+6% +$104K ﹤0.01% 3885
2022
Q2 		$1.81M Buy
44,490
+2,099
+5% +$81.5K ﹤0.01% 3845
2022
Q1 		$2.32M Sell
42,391
-7,516
-15% -$506K ﹤0.01% 3897
2021
Q4 		$4.89M Buy
49,907
+244
+0.5% +$46.3K ﹤0.01% 3622
2021
Q3 		$12.6M Buy
49,663
+17,309
+53% +$4.89M ﹤0.01% 3118
2021
Q2 		$10M Sell
32,354
-581
-2% -$236K ﹤0.01% 3200
2021
Q1 		$21.7M Buy
+32,935
New +$21.4M ﹤0.01% 2745

Other funds holding BOLT

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
T3 Companies New York $76.8M AUM
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group's BOLT Position: Q4 2025 in Review

Vanguard Group reduced its Bolt Biotherapeutics (BOLT) stake by 70% in Q4 2025, selling an estimated $129K and leaving 10,179 shares worth $55.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4231.

Vanguard Group first reported a position in BOLT in Q1 2021 and has held it in 20 quarters since. The position peaked at $21.7M in Q1 2021. 21 funds tracked by Wall St. Rank hold BOLT as of Q4 2025.

  • Vanguard Group held 10,179 shares of Bolt Biotherapeutics worth $55.8K as of Q4 2025.
  • Vanguard Group sold 24,052 Bolt Biotherapeutics shares in Q4 2025, an estimated $129K.
  • Bolt Biotherapeutics made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4231 holding.
  • Vanguard Group first reported a position in Bolt Biotherapeutics in Q1 2021 and has held it in 20 quarters since.
  • Vanguard Group's Bolt Biotherapeutics position peaked at $21.7M in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.